Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGIR | P43119 | 13/20 | 0.67 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.44 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.43 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.39 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.38 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.38 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8858455 | 0.94 | PTGIR (0.61) | PTGIRPTGDR2TBXAS1PTGER1PTGER3 | |
| SCHEMBL9046416 | 0.89 | PTGIR (0.70) | PTGIRPTGDR2TBXAS1 | |
| SCHEMBL8858467 | 0.84 | PTGIR (0.53) | PTGIRPTGDR2TBXAS1LIPG | |
| SCHEMBL9427087 | 0.82 | PTGIR (0.81) | PTGIRPTGDR2TBXAS1 | |
| SCHEMBL9047848 | 0.81 | PTGIR (0.43) | PTGIR | |
| SCHEMBL8858692 | 0.80 | PTGIR (0.65) | PTGIRPTGDR2TBXAS1LIPGPTGER1 | |
| SCHEMBL8858688 | 0.80 | PTGIR (0.65) | PTGIRPTGDR2TBXAS1LIPGPTGER1 | |
| SCHEMBL9048557 | 0.80 | PTGIR (1.00) | PTGIRPTGDR2TBXAS1 | |
| SCHEMBL7777393 | 0.79 | PTGIR (0.74) | PTGIRPTGDR2TBXAS1PTGER1PTGER3 | |
| SCHEMBL8858726 | 0.79 | PTGIR (0.56) | PTGIRPTGDR2TBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5596009-A | TREATMENT OF THROMBOSIS, ATHERIOSCLEROSIS, ANTIISCHEMIC AGENTS, ANTIULCER AGENTS OR HYPOTENSIVE AGENTS | ONO PHARMACEUTICAL CO., LTD. (JP) | 1997-01-21 | — | — | US | disclosed |